A new test for cervical cancer was found to detect all of the cancers in a randomised clinical screening trial of 15,744 women, outperforming both the current Pap smear and human papillomavirus (HPV) test at a reduced cost, ...
Dec 17, 2018
0
9
Women who do not respond to invitations to attend cervical cancer screening could be sent kits and asked to take their own vaginal samples at home so that samples can be sent to a laboratory for testing, suggests a study ...
Dec 5, 2018
0
1
AIDS patients suffer higher rates of cancer because they have fewer T-cells in their bodies to fight disease. But new research examines why HIV-infected patients have higher rates of cancer—among the leading causes of death ...
Dec 5, 2018
0
34
Screening women for HPV, or human papillomavirus, is a promising way to help detect cervical cancer early, but many at-risk women go without screening for the virus and without Pap tests that look for abnormal cells on the ...
Nov 28, 2018
0
1
University of North Carolina Lineberger Comprehensive Cancer Center researchers have found that mailing self-collection kits to test for high-risk human papillomavirus infection has the potential to boost cervical cancer ...
Nov 7, 2018
0
43
A new technology being tested by University of Alberta scientists could revolutionize human papillomavirus (HPV) related cancer diagnostics and cervical cancer screening.
Nov 5, 2018
0
20
A single negative human papillomavirus (HPV) DNA test—a newly introduced test which can detect cases of 14 high risk HPV strains to a high degree of accuracy—at the age of 55 suggests that women will be at low risk of ...
Nov 2, 2018
0
4
A just-released study found that American Indian and Alaska Native (AIAN) women are at greater risk of HPV and cervical cancer than their white counterparts.
Nov 1, 2018
0
2
Social vulnerability showed to be a major limitation to participation in cancer screening for four tumors types—breast, cervical, colorectal and lung—according to the French nationwide observational survey, EDIFICE 6. ...
Oct 20, 2018
0
3
(HealthDay)—U.S. Food and Drug Administration approval of the Gardasil 9 human papillomavirus (HPV) vaccine has been expanded to include people ages 27 through 45, the agency said in a news release.
Oct 9, 2018
0
15
